A Drug Interaction Study of Sorafenib (BAY 43-9006 Tosylate) and Rapamycin [sirolimus] in Patients With Advanced Malignancies.

Trial Profile

A Drug Interaction Study of Sorafenib (BAY 43-9006 Tosylate) and Rapamycin [sirolimus] in Patients With Advanced Malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Feb 2010

At a glance

  • Drugs Sirolimus; Sorafenib
  • Indications Solid tumours
  • Focus Pharmacokinetics
  • Most Recent Events

    • 02 Feb 2010 Actual end date (Sep 2009) and actual number of patients (34) added as reported by ClinicalTrials.gov.
    • 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Oct 2009 Planned end date changed from 1 May 2009 to 1 May 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top